Bayer Kogenate FS
Bayer HealthCare, Biological Products Division

Contact Search Press Sitemap  
HomePatients & CaregiversHealthcare ProfessionalsPrescribing Information
Prescribing Information
Important Safety Information
Administration
HCP Video
Product Benefits
Efficacy
Simplicity
Safety
Hemophilia Awards
EZ-Log
Bayer Factor Solutions
Rep Finder
Summer Camps
Patient Education Materials
HCP Resources
HCP FAQ
Bayer Links
Bayer Global
Living with Hemophilia
   General Conditions of Use
Privacy Statement
Imprint
  
 
  

Kogenate® FS, Antihemophilic Factor (Recombinant), brings a new level of convenience to the treatment of hemophilia A, while increasing the safety margin. In addition to an albumin-free final formulation, we have introduced a solvent/detergent step - a robust virus-inactivation process. Kogenate FS also features small diluent volumes, of 2.5 mL or 5 mL, for all vial sizes.

If you use 250, 500, or 1,000 IU vials of Kogenate FS, these vial sizes are reconstituted with 2.5 mL of sterile water. The 2000 IU vial size of Kogenate FS is reconstituted with 5 mL of sterile water. That's one quarter of the diluent volume required by some rFVIII products.

Convenient:

  • For administering to babies and children

  • For those with busy, active lifestyles

  • For those who treat bleeds frequently

  • For children learning to self-infuse

  • For larger patients with high-IU dosage, which fits in one syringe

1Data on File, Bayer HealthCare.

2Butler R, Jaworski K, Zappa, S, et al. Clinical convenience of low volume factor VIII infusions in pediatric hemophilia patients.Haemophilia. 2004;10(s3):114.





Bayer Hemophila Awards
Bayer provides grants
to early career investigators, fellows in training, and other allied healthcare professionals.
Learn More




Join Now!
Join our mailing list. It's simple and fast.
Join Now


 
  

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.